Related Experiment Video

Updated: Aug 5, 2026

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
14:57

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology

Published on: March 23, 2011

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

C R Jack1, D W Dickson, J E Parisi

  • 1Department of Diagnostic Radiology, Mayo Clinic and Foundation, Rochester, MN 55905, USA. jack.clifford@may.edu

Neurology
|March 13, 2002
PubMed
Abstract

Insights

Hippocampal atrophy on MRI is a sensitive marker for Alzheimer's disease (AD) pathology stage and cognitive status, though not specific to AD. This finding aids in understanding dementia progression.

Area of Science:

  • Neurology
  • Radiology
  • Pathology

Background:

  • Alzheimer's disease (AD) diagnosis relies on clinical assessment and biomarkers.
  • Hippocampal atrophy is a known indicator in AD, but its specificity across various dementia pathologies requires clarification.

Purpose of the Study:

  • To evaluate the diagnostic specificity of MRI-detected hippocampal atrophy for AD.
  • To correlate antemortem MRI findings with postmortem pathological staging and cognitive performance.

Main Methods:

  • A cohort of 67 individuals with antemortem MRI and postmortem examination data was analyzed.
  • Hippocampal volumes were measured via MRI; postmortem specimens were pathologically diagnosed and staged for AD severity (Braak and Braak).

Main Results:

  • Substantial hippocampal atrophy was observed in AD, hippocampal sclerosis, frontotemporal degeneration, and neurofibrillary tangle-only degeneration, but not in typical aging.
  • Significant correlations were found between hippocampal volume and Braak and Braak stage (r=-0.39), hippocampal volume and Mini-Mental State Examination (MMSE) score (r=0.60), and MMSE score and Braak and Braak stage (r=-0.41).

Conclusions:

  • MRI-defined hippocampal atrophy is a sensitive, though not entirely specific, marker for the pathological stage of AD.
  • Hippocampal atrophy correlates with cognitive status and the severity of AD pathology.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...